Proinflammatory cytokines, oxidative stress, and organ function as biomarkers of soman (GD) chronic neurotoxicity.

Nyzil Massey, Suraj S Vasanthi, Luis G Gimenez-Lirola, Harm Tyler, Thimmasettappa Thippeswamy
Author Information
  1. Nyzil Massey: Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA, USA.
  2. Suraj S Vasanthi: Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA, USA.
  3. Luis G Gimenez-Lirola: Vet Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA, USA.
  4. Harm Tyler: Department of Veterinary Pathology, College of Veterinary Medicine, Iowa State University, Ames, IA, USA.
  5. Thimmasettappa Thippeswamy: Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA, USA. tswamy@iastate.edu.

Abstract

Organophosphate (OP) nerve agents, such as soman (GD), pose great risk to neurological health by inhibiting acetylcholinesterase, leading to seizures, epilepsy, and Behavioral deficits. While acute treatment may alleviate immediate symptoms, the long-term consequences, particularly those involving neuroinflammation and systemic toxicity, remain poorly understood. This study used adult male and female Sprague Dawley rats to investigate the chronic effects of a single acute exposure to soman (132 ��g/kg, s.c., 1.2��������LD) on neuroinflammation, behavioral comorbidity, and systemic toxicity. Following exposure, animals were treated with atropine sulfate (2 mg/kg, i.m.) and oxime HI-6 (125 mg/kg, i.m.) to mitigate peripheral cholinergic effects, and with midazolam (3 mg/kg, i.m., 1 h post-exposure) to control seizures. Spontaneously recurring seizures were monitored during handling and with video electroencephalogram (vEEG). Neurobehavioral deficits were assessed 4-8 weeks post-exposure. At 18 weeks post-exposure, brain, serum, and cerebrospinal fluid (CSF) were analyzed for inflammatory and nitro-oxidative stress markers, and the liver and kidney function biomarkers were evaluated. soman-exposed animals developed epilepsy, confirmed by handling-induced seizures and/or continuous vEEG monitoring. Behavioral assessments revealed significant memory deficits following soman exposure. Proinflammatory cytokines (TNF-��, IL-6, IL-1��, IL-18, IL-17A, and MCP-1) were significantly elevated in both serum and CSF, alongside corresponding increases in their gene expression in the brain. Elevated reactive oxygen/nitrogen species were detected in the serum. Although hematological parameters remained unchanged, a significant increase in total bilirubin and an upward trend in serum blood urea nitrogen (BUN) levels and BUN: Creatinine ratio indicated potential liver and kidney dysfunction. However, no significant structural changes in these organs at the cellular level were observed in histological analyses. This study identifies critical chronic biomarkers of soman exposure affecting the brain, serum, CSF, liver, and kidney. The findings highlight the critical need to monitor systemic and neurological impacts, as well as organ function, to develop effective diagnostic and therapeutic strategies for survivors of nerve agent exposure or OP pesticide poisoning. Behavioral deficits and EEG changes in soman-exposed animals further emphasize the long-term neurological consequences of exposure.

Keywords

References

  1. Clin Chem. 2012 Apr;58(4):680-9 [PMID: 22311920]
  2. Neurobiol Dis. 2021 Aug;156:105410 [PMID: 34087381]
  3. Nat Protoc. 2013 Dec;8(12):2531-7 [PMID: 24263092]
  4. Front Cell Dev Biol. 2022 May 10;10:895092 [PMID: 35620057]
  5. ChemistryOpen. 2014 Aug;3(4):142-5 [PMID: 25478309]
  6. Proc Natl Acad Sci U S A. 2021 Apr 13;118(15): [PMID: 33833060]
  7. Neurochem Res. 2024 Apr;49(4):834-846 [PMID: 38227113]
  8. QJM. 2002 May;95(5):275-83 [PMID: 11978898]
  9. Environ Health Perspect. 1994 Dec;102 Suppl 11:51-60 [PMID: 7737042]
  10. Epilepsia. 2008;49 Suppl 2:24-32 [PMID: 18226169]
  11. Arch Toxicol. 2023 Jul;97(7):1873-1885 [PMID: 37264164]
  12. J Neuroinflammation. 2023 Jul 12;20(1):163 [PMID: 37438764]
  13. Front Cell Neurosci. 2022 Feb 07;15:798247 [PMID: 35197823]
  14. Glia. 2013 Jul;61(7):1113-21 [PMID: 23625868]
  15. Neurobiol Dis. 2016 Sep;93:184-200 [PMID: 27208748]
  16. Front Neurol. 2021 Jun 03;12:651096 [PMID: 34149593]
  17. Brain Behav Immun Health. 2021 Dec 11;19:100401 [PMID: 34977822]
  18. Nat Rev Neurosci. 2019 May;20(5):282-297 [PMID: 30792501]
  19. J Pharmacol Toxicol Methods. 2019 May - Jun;97:1-12 [PMID: 30790623]
  20. Front Mol Neurosci. 2023 Mar 17;16:1125934 [PMID: 37008784]
  21. Antioxidants (Basel). 2023 Nov 30;12(12): [PMID: 38136181]
  22. Brain Behav Immun. 2011 Oct;25(7):1281-9 [PMID: 21473909]
  23. Sci Adv. 2021 Sep 17;7(38):eabf4468 [PMID: 34524838]
  24. Cell Mol Life Sci. 2017 Sep;74(18):3275-3291 [PMID: 28389721]
  25. Transl Psychiatry. 2021 Apr 28;11(1):251 [PMID: 33911072]
  26. Clin J Am Soc Nephrol. 2022 Jul;17(7):1039-1049 [PMID: 35584927]
  27. Neurobiol Dis. 2018 Feb;110:102-121 [PMID: 29197620]
  28. Front Microbiomes. 2022;1: [PMID: 37304619]
  29. Physiol Zool. 1997 Nov-Dec;70(6):718-20 [PMID: 9361146]
  30. J Toxicol Clin Toxicol. 2004;42(6):865-75 [PMID: 15533026]
  31. Biomed Res Int. 2015;2015:745613 [PMID: 25650148]
  32. Front Neurol. 2017 Mar 17;8:92 [PMID: 28367138]
  33. Liver Int. 2022 Dec;42(12):2713-2723 [PMID: 36264137]
  34. Nat Methods. 2019 Jul;16(7):565-566 [PMID: 31217592]
  35. Mil Med. 1990 Jun;155(6):244-9 [PMID: 2122298]
  36. Clin Kidney J. 2012 Dec;5(6):582-3 [PMID: 26069807]
  37. Epilepsia. 2015 Jun;56(6):813-21 [PMID: 26032507]
  38. J Neuroinflammation. 2023 Oct 10;20(1):231 [PMID: 37817184]
  39. CNS Neurol Disord Drug Targets. 2011 May;10(3):391-403 [PMID: 21288189]
  40. Front Cell Neurosci. 2021 Oct 15;15:772868 [PMID: 34720886]
  41. J Toxicol. 2020 Sep 22;2020:3007984 [PMID: 33029136]
  42. J Neurosci Methods. 2009 Mar 30;178(1):116-9 [PMID: 19109998]
  43. Neurobiol Dis. 2020 Jan;133:104443 [PMID: 30940499]
  44. Neurotoxicology. 2021 Mar;83:14-27 [PMID: 33352274]
  45. Pharmacol Biochem Behav. 2001 Jul-Aug;69(3-4):561-9 [PMID: 11509217]
  46. J Pharmacol Exp Ther. 2024 Jan 17;388(2):724-738 [PMID: 38129129]
  47. Liver Int. 2023 Feb;43(2):268-270 [PMID: 36680317]
  48. Int J Emerg Med. 2013 Feb 27;6(1):6 [PMID: 23445821]
  49. Front Cell Dev Biol. 2021 Nov 05;9:740758 [PMID: 34805149]
  50. Br J Anaesth. 2019 Oct;123(4):457-463 [PMID: 31248646]
  51. Arh Hig Rada Toksikol. 2017 Dec 20;68(4):261-275 [PMID: 29337682]
  52. Toxicol Mech Methods. 2009 Oct;19(8):486-97 [PMID: 19788408]

Grants

  1. U01 NS117284/NINDS NIH HHS
  2. Grant U01 NS117284-01/National Institute of Health/NINDS CounterACT

MeSH Term

Animals
Soman
Oxidative Stress
Biomarkers
Cytokines
Male
Rats, Sprague-Dawley
Female
Rats
Neurotoxicity Syndromes
Seizures
Brain
Nerve Agents

Chemicals

Soman
Biomarkers
Cytokines
Nerve Agents

Word Cloud

Created with Highcharts 10.0.0exposuresomanserumseizuresdeficitsfunctionbiomarkersnerveneurologicalsystemicchronicanimalsimpost-exposurebrainCSFliverkidneysignificantOrganophosphateOPagentsGDepilepsybehavioralacutelong-termconsequencesneuroinflammationtoxicitystudyeffectsvEEGstressBehavioralProinflammatorycytokineschangescriticalorganneurotoxicityposegreatriskhealthinhibitingacetylcholinesteraseleadingtreatmentmayalleviateimmediatesymptomsparticularlyinvolvingremainpoorlyunderstoodusedadultmalefemaleSpragueDawleyratsinvestigatesingle132 ��g/kgsc12��������LDcomorbidityFollowingtreatedatropinesulfate2 mg/kgoximeHI-6125 mg/kgmitigateperipheralcholinergicmidazolam3 mg/kg1 hcontrolSpontaneouslyrecurringmonitoredhandlingvideoelectroencephalogramNeurobehavioralassessed4-8 weeks18 weekscerebrospinalfluidanalyzedinflammatorynitro-oxidativemarkersevaluatedSoman-exposeddevelopedconfirmedhandling-inducedand/orcontinuousmonitoringassessmentsrevealedmemoryfollowingTNF-��IL-6IL-1��IL-18IL-17AMCP-1significantlyelevatedalongsidecorrespondingincreasesgeneexpressionElevatedreactiveoxygen/nitrogenspeciesdetectedAlthoughhematologicalparametersremainedunchangedincreasetotalbilirubinupwardtrendbloodureanitrogenBUNlevelsBUN:CreatinineratioindicatedpotentialdysfunctionHoweverstructuralorganscellularlevelobservedhistologicalanalysesidentifiesaffectingfindingshighlightneedmonitorimpactswelldevelopeffectivediagnostictherapeuticstrategiessurvivorsagentpesticidepoisoningEEGsoman-exposedemphasizeoxidativeChronicNeuroinflammationOrganPeripheralSoman

Similar Articles

Cited By

No available data.